MustGrow Biologics Corp.
MGRO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 289.60K | 3.67M | 3.46M | 3.46M | 3.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 289.60K | 3.67M | 3.46M | 3.46M | 3.46M |
| Cost of Revenue | 229.90K | 187.60K | 178.00K | 282.90K | 285.40K |
| Gross Profit | 59.70K | 3.48M | 3.29M | 3.18M | 3.18M |
| SG&A Expenses | 2.79M | 2.82M | 2.71M | 2.72M | 2.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.58M | 3.53M | 3.41M | 3.61M | 3.65M |
| Operating Income | -3.29M | 133.80K | 49.90K | -144.30K | -187.60K |
| Income Before Tax | -3.57M | -179.80K | -334.00K | -526.50K | -532.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.57 | -0.18 | -0.33 | -0.53 | -0.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.57M | -179.80K | -334.00K | -526.50K | -532.90K |
| EBIT | -3.29M | 133.80K | 49.90K | -144.30K | -187.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.07 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.04 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.07 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.04 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 206.39M | 205.07M | 203.31M | 201.36M | 199.58M |
| Average Diluted Shares Outstanding | 206.39M | 205.07M | 203.31M | 201.36M | 199.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |